High viscosity hydroxypropylmethylcellulose reduces postprandial blood glucose concentrations in NIDDM patients
dc.contributor.author | Reppas, Christos | en_US |
dc.contributor.author | Adair, Constance H. | en_US |
dc.contributor.author | Barnett, Jeffrey L. | en_US |
dc.contributor.author | Berardi, Rosemary R. | en_US |
dc.contributor.author | DuRoss, Dan | en_US |
dc.contributor.author | Swidan, Sahar Z. | en_US |
dc.contributor.author | Thill, Paul F. | en_US |
dc.contributor.author | Tobey, Stephen W. | en_US |
dc.contributor.author | Dressman, Jennifer B. | en_US |
dc.date.accessioned | 2006-04-10T15:33:41Z | |
dc.date.available | 2006-04-10T15:33:41Z | |
dc.date.issued | 1993 | en_US |
dc.identifier.citation | Reppas, Christos, Adair, Constance H., Barnett, Jeffrey L., Berardi, Rosemary R., DuRoss, Dan, Swidan, Sahar Z., Thill, Paul F., Tobey, Stephen W., Dressman, Jennifer B. (1993)."High viscosity hydroxypropylmethylcellulose reduces postprandial blood glucose concentrations in NIDDM patients." Diabetes Research and Clinical Practice 22(1): 61-69. <http://hdl.handle.net/2027.42/30526> | en_US |
dc.identifier.uri | http://www.sciencedirect.com/science/article/B6T5Y-4BY500T-CS/2/beec9ea4945e5abc4d4e81e404490ab7 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/30526 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=8137718&dopt=citation | en_US |
dc.description.abstract | The ability of high viscosity hydroxypropylmethylcellulose (HPMC) to reduce postprandial glucose concentrations was assessed in patients with non-insulin-dependent diabetes (NIDDM) and healthy volunteers. The study design consisted of a two-way crossover, single-dose administration of 10 g prehydrated high viscosity HPMC, or placebo, with a standard carbohydrate-rich meal. In patients with NIDDM, HPMC reduced blood glucose concentrations at the 60-, 75-, 90-, 120- and 150-min sampling intervals, with an average reduction in the maximum postprandial blood glucose concentration, Cmax, of 24% (P Tmax, remained unchanged. The area under the blood concentration versus time plot, AUC0-6h, was reduced by an average of 15% (P Cmax, Tmax and AUC0-6h) were unchanged. These results suggest that alterations in the blood glucose profile are mediated by luminal events rather than by changes in hormonal response. In contrast to the NIDDM patients, neither the pharmacokinetic parameters nor the blood glucose concentrations at specific sampling times were significantly affected by the coadministration of HPMC in healthy volunteers. Overall, the results of this study suggest that HPMC may be a useful adjunct in the management of NIDDM. | en_US |
dc.format.extent | 835716 bytes | |
dc.format.extent | 3118 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.language.iso | en_US | |
dc.publisher | Elsevier | en_US |
dc.title | High viscosity hydroxypropylmethylcellulose reduces postprandial blood glucose concentrations in NIDDM patients | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Internal Medicine and Specialties | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | General Clinical Research Center, The University of Michigan, Ann Arbor, MI 48109-1065, USA | en_US |
dc.contributor.affiliationum | Department of Internal MEdicine, The University of Michigan, Ann Arbor, MI 48109-1065, USA | en_US |
dc.contributor.affiliationum | College of Pharmacy, The University of Michigan, Ann Arbor, MI 48109-1065, USA | en_US |
dc.contributor.affiliationum | General Clinical Research Center, The University of Michigan, Ann Arbor, MI 48109-1065, USA | en_US |
dc.contributor.affiliationum | College of Pharmacy, The University of Michigan, Ann Arbor, MI 48109-1065, USA | en_US |
dc.contributor.affiliationum | College of Pharmacy, The University of Michigan, Ann Arbor, MI 48109-1065, USA | en_US |
dc.contributor.affiliationum | College of Pharmacy, The University of Michigan, Ann Arbor, MI 48109-1065, USA | en_US |
dc.contributor.affiliationother | Department of Pharmacy, University of Athens, Athens, Greece | en_US |
dc.contributor.affiliationother | The Dow Chemical Company, Midland, MI, USA | en_US |
dc.identifier.pmid | 8137718 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/30526/1/0000158.pdf | en_US |
dc.identifier.doi | http://dx.doi.org/10.1016/0168-8227(93)90133-P | en_US |
dc.identifier.source | Diabetes Research and Clinical Practice | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.